1. Precision Management of RA and Comorbidities

3. Introduction

4. Patient Case

5. How is Adipose Tissue Related to Inflammation in the Body?

6. How Does Obesity Affect RA Activity?

7. Measuring BMI in Patients With RA

8. Assessing Disease Activity in RA in the Setting of Obesity

9. Accurately Assessing Obesity in Practice

10. Assessing RA in the Setting of Obesity

11. Effect of Obesity on Radiographic Progression

12. Evaluation of the MBDA Test in Relation to Obesity

13. Leptin-Adjusted MBDA Score to Predict Radiographic Progression in Patients With RA

14. Effect of Weight Loss on Disease Activity in Patients With Inflammatory Arthritis

15. Assessing CVD Risk in RA

16. Addressing Traditional CV Risk Factors in Patients With RA

17. RA Pharmacotherapies and CVD Risk

18. CV Events in Patients Treated With Different RA Pharmacotherapies

19. Treatment Response in Patients With RA and Obesity

20. Patient Case Considerations for Next Steps

21. Concluding Remarks

22. Abbreviations

23. Abbreviations (cont)